A cohort of 270 OPMD and malignant tissue samples obtained from 128 patients was evaluated for CD4, CD8, FoxP3, CD25, PD-1 and PD-L1. The gene discussed is CD8A; the disease is oculopharyngeal muscular dystrophy.